{"id":3320,"date":"2023-04-09T00:17:51","date_gmt":"2023-04-08T18:47:51","guid":{"rendered":"https:\/\/edunovations.com\/currentaffairs\/?p=3320"},"modified":"2023-05-04T00:18:12","modified_gmt":"2023-05-03T18:48:12","slug":"bharat-biotech-has-won-the-best-covid-19-vaccine-award-at-the-world-vaccine-congress-for-its-vaccine-covaxin","status":"publish","type":"post","link":"https:\/\/edunovations.com\/currentaffairs\/awards_medals\/bharat-biotech-has-won-the-best-covid-19-vaccine-award-at-the-world-vaccine-congress-for-its-vaccine-covaxin\/","title":{"rendered":"Bharat Biotech’s Covaxin Wins “Best Covid-19 Vaccine” Award at World Vaccine Congress"},"content":{"rendered":"\n

Bharat Biotech, an Indian biotechnology company, has won the “Best Covid-19 Vaccine” award at the World Vaccine Congress. The company received the award for its vaccine, Covaxin, which has been developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).<\/p>\n\n\n\n

Covaxin is an inactivated vaccine, which means that it uses a weakened or dead form of the virus to stimulate an immune response in the body. It has been shown to be effective against the original strain of Covid-19, as well as against the Delta variant, which is currently the dominant strain in India. Covaxin has also been found to produce a strong immune response, including the production of neutralizing antibodies, which are critical in preventing severe disease.<\/p>\n\n\n\n

This award is a significant achievement for Bharat Biotech and India, as it recognizes the company’s contribution to the fight against Covid-19. Covaxin is one of the two vaccines currently being used in India’s vaccination drive, and its effectiveness against the Delta variant has been crucial in controlling the spread of the virus in the country. The award is also a recognition of the scientific capabilities and expertise of Indian scientists and researchers in the field of biotechnology and vaccine development.<\/p>\n\n\n\n

Bharat Biotech has been at the forefront of vaccine development in India for several years, having developed vaccines for a range of diseases, including rotavirus, typhoid, and Japanese encephalitis. The company has also collaborated with several international organizations, including the World Health Organization (WHO), to develop and distribute vaccines globally.<\/p>\n\n\n\n

In conclusion, Bharat Biotech’s achievement at the World Vaccine Congress is a testament to the company’s dedication to developing vaccines that are safe, effective, and accessible. Covaxin’s success against the Delta variant has been crucial in India’s fight against the pandemic, and the award recognizes the important role played by Indian scientists and researchers in the global fight against Covid-19.<\/p>\n\n\n

\n
\"
Bharat Biotech<\/figcaption><\/figure>\n<\/div>\n\n\n
\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n